Sanjay Popat/royalmarsden.nhs.uk
May 20, 2025, 12:13
Sanjay Popat: NHS England Funding for ctDNA NGS in Advanced NSCLC
Sanjay Popat, Professor at The Institute of Cancer Research, shared a post on X:
“Great to see ctDNA NGS is now fully funded by NHS England for routine blood draw at presentation of advanced NSCLC to clinic or as emergency admission
Now we need max implementation for max benefit!”
Sanjay Popat announced that NHS England now fully funds circulating tumor DNA next-generation sequencing (ctDNA NGS) for advanced NSCLC patients, whether presenting in clinic or via emergency admission. He called for broad implementation to ensure the full benefit of this policy.
More posts featuring Sanjay Popat.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 1, 2025, 16:47
Jul 1, 2025, 16:16
Jul 1, 2025, 10:32